APP/PS1 AD mice treated with CPO_ Aβ17-21 P had a significant cognitive improvement, reduction of soluble and insoluble Aβ peptide/oligomer levels in brain and lower total amyloid burden in cortex and hippocampus. The gene discussed is APP; the disease is Alzheimer disease.